Lactobacillus brevis MAK11L82B and Ensured Safety for Human Consumption

• Safety assessment of Lactobacillus brevis KB290 as a probiotic strain.

  • 2009-10
  • Clinical Trial
  • Food and Chemical Toxicology 47(10)
  • • T. Yakabe
    • E. Moore
    • S. Yokota
    • H. Sui
    • Y. Nobuta
    • M. Fukao
    • H. Palmer
    • N. Yajima

  • PubMed: 19583990
  • DOI: 10.1016/j.fct.2009.07.001

  7 Insights on

  • Ensured Safety for Human Consumption

  • Low evidence
  • Animal Study
  • Clinical

  Based on those results, we consider 10(10) cfu/kg per day, the highest dose tested, to be the no observed adverse effect level (NOAEL). These results suggest that KB290 is safe for human consumption.

  Effect

  Neutral

  Effect size

  Large